TrialEuropean heart journal2021

The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy-the IRON-CRT trial.

Pieter Martens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.